Teach me this topic from this 2 pdf alone for exam in pediatrics today.. make me understand this and teach everything in this in short enough to attend mcqs .. please fast pls

Reading File
Running Command
Got everything. Here's your full exam-ready crash course - everything from both PDFs, organized for fast MCQ recall:

🏥 PEDIATRIC JAUNDICE IN OLDER CHILDREN - EXAM CRASH COURSE


📌 PART 1: TABLE 362-2 PDF


🔴 JAUNDICE IN OLDER CHILDREN - OVERVIEW

  • Jaundice = total bilirubin >1 mg/dL
  • Much less common in older children vs neonates
  • Two types:
TypeKey Conditions
UnconjugatedHemolytic anemia, Gilbert syndrome, Crigler-Najjar
ConjugatedViral hepatitis, metabolic disease, biliary disorders, autoimmune

🟡 UNCONJUGATED HYPERBILIRUBINEMIA

Gilbert Syndrome

  • Rare autosomal recessive
  • Defect in UDPGT (UDP glucuronosyl transferase)
  • Mild unconjugated bili (usually ≤5 mg/dL); otherwise healthy
  • Triggered by: infection, fasting, vigorous exercise

Crigler-Najjar Syndrome

  • Type 1: Complete absence of UDPGT - severe, life-threatening
  • Type 2: Limited activity of UDPGT - less severe
  • Phenobarbital can induce the enzyme in Type 2 (not Type 1!)
💡 MCQ trick: Phenobarbital works in Crigler-Najjar Type 2 only

🟠 VIRAL HEPATITIS

Key Distinguishing Features (HIGH-YIELD!)

FeatureHAVHBVHCVHDVHEV
Incubation15-19 days (shortest!)3 months (avg)---
RouteFecal-oralBlood/body fluidsBloodBloodFecal-oral
Acute only---
Chronic
Fulminant--
Perinatal-✅ (up to 90%)-

HAV Key Points

  • RNA virus, Picornavirus family
  • Most common cause of viral hepatitis
  • Asymptomatic in <5 yr old, symptomatic in older
  • Communicable: 2 weeks BEFORE to 7 days AFTER jaundice
  • Duration: 7-14 days
  • Dx: Anti-HAV (detectable when symptoms appear; positive for 4-6 months)
  • Vaccine: at 12 months, booster at least 6 months after
  • Complications: Acute liver failure, prolonged cholestatic syndrome

HBV Key Points

  • dsDNA virus, Hepadnaviridae family; 8 genotypes (A-H); B & C prevalent in Asia
  • Perinatal transmission: up to 90% if mother is HBeAg-positive and untreated
  • Does NOT spread by breastfeeding, kissing, hugging, or sharing utensils
  • Pathogenesis: immune-mediated (predominant in HBV)
  • Chronic treatment: only in immune-active form (elevated ALT/AST + progressive fibrosis)

Lab findings in Viral Hepatitis

  • ALT/AST elevated - does NOT correlate with severity
  • Rapidly falling ALT + rising PT = POOR outcome!
  • Conjugated bilirubin normalizes first (before ALT/AST)
  • ALP, 5-nucleotidase, GGT, urobilinogen elevated during acute phase

🔵 AUTOIMMUNE HEPATITIS (AIH)

Type 1 vs Type 2 - Classic MCQ!

FeatureType 1Type 2
AutoantibodiesANA, anti-SMA (anti-smooth muscle), anti-actinAnti-LKM1 (liver-kidney microsome), anti-LC1
AgeAny agePredominantly childhood
GenderFemale ~75%Female ~95%
Treatment failureInfrequentFrequent
Need for long-term maint.Variable~100%
Relapse after withdrawalVariableCommon

Diagnosis Criteria

  • Positive: Female + elevated transaminases (NOT ALP) + elevated γ-globulin + autoantibodies
  • Negative: no viral markers, no drug/blood exposure, negligible alcohol

Labs

  • Aminotransferase: 100-300 IU/L (up to 1,000 IU/L in symptomatic)
  • Bilirubin: 2-10 mg/dL
  • IgG >16 g/L (hypergammaglobulinemia)
  • Associated HLA: DR3, DR4, DR7

Treatment

  • Prednisone 1-2 mg/kg/day, then taper to 0.1-0.3 mg/kg/day
  • Poor responders add: Azathioprine or 6-mercaptopurine
  • Goal: ALT <2x upper limit of normal
  • 75% remission on initial therapy; 50% relapse after withdrawal
  • Progression to cirrhosis → liver transplant

🟢 DRUG-INDUCED LIVER INJURY (DILI) - Table 363-1

Drug Patterns (HIGH-YIELD TABLE!)

PatternDrug
Centrilobular necrosisAcetaminophen, Halothane
Microvesicular steatosisValproic acid
Acute hepatitisIsoniazid
General hypersensitivitySulfonamides, Phenytoin
FibrosisMethotrexate
CholestasisChlorpromazine, Erythromycin, Estrogens
Sinusoidal obstruction (veno-occlusive)Irradiation + Busulfan, Cyclophosphamide
Portal/hepatic vein thrombosisEstrogens, Androgens
Biliary sludgeCeftriaxone
Hepatic adenoma / HCCOral contraceptives, Anabolic steroids

CYP450 Inducers (memorize!)

Ethanol, Phenobarbital, Phenytoin, Carbamazepine, Rifampicin, INH, Omeprazole

DILI Patterns

  • Hepatitic: fatigue, anorexia, vomiting; isolated aminotransferase elevation
  • Cholestatic: jaundice, pruritus; elevated ALP & GGT; mild aminotransferases
  • Mixed: both
  • Drug hypersensitivity: fever, rash, eosinophilia, lymphadenopathy, multi-organ

Treatment

  • AcetaminophenN-acetylcysteine (within 16 hr!)
  • Valproic acidIV L-carnitine

🟣 WILSON'S DISEASE

  • Autosomal recessive copper storage disease
  • Defect in ATP7B gene → defective ceruloplasmin incorporation → copper accumulates
  • Hepatolenticular degeneration
  • Hepatic involvement precedes neurologic manifestation by up to 10 yr
  • Acute liver failure: 3x more common in girls
  • Manifests as early as 2-3 yr (complete gene absence)

Think Wilson's when:

Unexplained liver disease + neurologic symptoms + acute hemolysis + psychiatric changes + Fanconi syndrome + bone/muscle disease

Treatment

  • Dietary copper restriction <1 mg/day (avoid liver, shellfish, nuts, chocolate)
  • D-Penicillamine (chelation)
  • Trientine (alternative chelation)
  • Zinc 25 mg 3x/day in children >5 yr (adjuvant/maintenance/primary)
  • Liver transplant: 85-90% survival, curative

🟤 CHOLEDOCHAL CYST

  • Congenital dilation of biliary tree
  • 75% cases manifest during childhood
  • Classic triad in older children: Abdominal pain + Jaundice + Mass
  • Infants: cholestatic jaundice (dark urine, acholic stool)
  • Acute cholangitis: fever + RUQ pain + jaundice + leukocytosis
  • Dx: Ultrasonography or MRCP
  • Treatment: Primary excision + Roux-en-Y choledochojejunostomy

⚪ LIVER ABSCESS

  • Usually seen <6 yr old
  • 70% solitary; 75% in right lobe
  • Most common organism: S. aureus, Streptococcus spp., E. coli, Klebsiella, Salmonella
  • In endemic areas: Entamoeba histolytica (amoebic abscess)
  • 50% are polymicrobial; cryptogenic = often monomicrobial
  • Imaging: Elevated hemidiaphragm on CXR; Ultrasound/CT preferred
  • Treatment:
    • Broad-spectrum antibiotics IV 2-3 weeks, then oral to complete 4-6 weeks
    • Amoebic: Metronidazole + Paromomycin
    • Multiple/large abscess: CT-guided aspiration or surgical drainage

🔴 ACUTE ACALCULOUS CHOLECYSTITIS

  • Uncommon in children; no gallstones
  • Most common cause: Infection (Streptococci groups A & B, gram-negative - Salmonella, Leptospira; Parasites - Ascaris, Giardia)
  • Dx: US - enlarged, thick-walled gallbladder without calculi; daily US recommended (can become gangrenous)
  • Treatment: Antibiotics + Cholecystectomy

📌 PART 2: TYPES OF STONES / CHOLELITHIASIS PDF


💛 CHOLELITHIASIS (Gallstones)

  • Rare in healthy children; common with predisposing factors
  • 70% pigment stones (most common in children!)
  • 15-20% cholesterol stones
  • <15% mixed

Pathophysiology

  • Cholesterol stones: gallbladder stasis + excess cholesterol → supersaturation → crystallization
  • Co-factors: mucin, calcium, apolipoprotein, lecithin
  • Biliary pseudolithiasis: Calcium-Ceftriaxone salt precipitates
    • Prolonged high-dose Ceftriaxone (>40% treated ≥10 days)
    • Presents with jaundice, abdominal pain
    • Spontaneously resolves within several months

Clinical Presentation

  • >50% have symptoms
  • 18% present with complications (pancreatitis, choledocholithiasis, acute cholecystitis)
  • Key feature: recurrent colicky pain in RUQ
  • Older child: intolerance for fatty foods

Diagnosis

  • Ultrasonography = method of choice
  • Plain x-ray: only radiopaque (calcified) stones visible; radiolucent = not seen
  • Hepatobiliary scintigraphy (HIDA scan): adjunct; shows cholecystitis

Treatment

  • Symptomatic: Laparoscopic cholecystectomy
  • Operative cholangiography: at surgery to detect unsuspected CBD stones
  • ERCP with extraction: older children and adolescents
  • Asymptomatic: May resolve spontaneously; advise parents

🔴 QUICK COMPARISON TABLE (HIGH-YIELD!)

CholelithiasisCholecystitisCholedocholithiasisCholangitis
MeaningStones in GBInflammation GB/cystic ductStones in CBDInflammation of bile ducts
SymptomsRUQ pain (biliary colic), N/VRUQ pain, N/V, FeverRUQ pain, JaundiceRUQ pain, Jaundice, Fever
DiagnosisRUQ USRUQ US + HIDARUQ US + ERCP/MRCPRUQ US + ERCP/MRCP
TreatmentElective cholecystectomyAntibiotics + cholecystectomyERCPAntibiotics + ERCP + cholecystectomy

🟠 ACUTE PANCREATITIS

Etiology (Children)

  • Most common pancreatic disorder in children
  • Top causes:
    1. Blunt abdominal injuries (most common cause)
    2. Hemolytic uremic syndrome (HUS)
    3. Inflammatory bowel disease
    4. Biliary stones / microlithiasis
    5. Drug toxicity: valproic acid, L-asparaginase, 6-mercaptopurine, azathioprine

Pathophysiology

  • Ductal disruption → premature activation of trypsinogen → trypsin → activates proenzymes → autodigestion

Severity Classification (HIGH-YIELD!)

MildModerately SevereSevere
Organ failureNoneTransient (<48h)Persists >48h
NecrosisNoneSterile necrosis possibleHemorrhagic mass
SignsAbdominal pain, vomiting-Cullen sign (periumbilical blue) + Grey Turner sign (flank blue)
PrognosisExcellent; resolves in 1st week-20% mortality
💡 Cullen sign = periumbilical bluish discoloration; Grey Turner = flanks - both = Severe pancreatitis

Diagnosis: Lipase vs Amylase

Lipase (preferred!)Amylase
WhyMore specific for pancreatitisElevated in non-pancreatic diseases too
Rises4-8 hr, peaks 24-48 hrUp to 4 days
Stays elevated8-14 days longer-
Normal at startNo10-15% initially normal
Other labs: hemoconcentration, leukocytosis, hyperglycemia, glucosuria, hypocalcemia, elevated GGT, hyperbilirubinemia
  • CT scan for severe: pancreatic enlargement, hypoechoic edematous pancreas, fluid collections, abscess
  • MRCP/ERCP: recurrent or non-resolving pancreatitis

Treatment

MildSevere
AnalgesiaAntibiotics
Fluid/electrolyte balanceGastric acid suppression
NPO if vomiting; refeed with resolution of vomitingEnteral feeding within 2-3 days
Endoscopic/surgical therapy for complications
  • Prognosis: Uncomplicated → recovery in 4-5 days

🔵 PORTAL HYPERTENSION

  • Portal pressure >10-12 mm Hg (normal: 7 mm Hg)

Causes by Location

Prehepatic (extrahepatic)IntrahepaticPosthepatic
Portal vein thrombosis (most common in children)Cirrhosis (predominant)Budd-Chiari syndrome
OmphalitisCongenital hepatic fibrosisVeno-occlusive disease
AV fistulaSchistosomiasisIVC occlusion
Portal vein anomaliesMalignant infiltrationRight heart dysfunction
💡 Suspect portal vein obstruction in a child <6 yr with isolated splenomegaly who had a complicated neonatal course

Clinical Manifestations

  1. Most common: Esophageal variceal bleed (hematemesis/melena)
    • Hard to control if secondary to cirrhosis
  2. 2nd most common: Splenomegaly (with/without hypersplenism)
  3. Ascites (more common in intrahepatic disease)
  4. Growth retardation (cirrhosis > extrahepatic)
  5. Hepatopulmonary syndrome: ≥10% of patients; arterial oxygenation defect from intrapulmonary microvascular dilation

Diagnosis

  • Doppler US: reversal of portal flow (hepatofugal flow) = variceal bleeding
  • Endoscopy: most reliable for detecting esophageal varices + source of GI bleed
  • Best noninvasive predictors: Platelet count + spleen length + serum albumin
  • Contrast echocardiography: for hepatopulmonary syndrome - delayed appearance of microbubbles in left heart

Treatment - Acute Variceal Bleed

  • Fluid resuscitation → RBC transfusion
  • IV H2 blocker or PPI
  • Vitamin K + platelets/FFP (if coagulopathy)
  • Vasopressin → increases splanchnic vascular tone → decreases portal blood flow
  • Octreotide → decreases splanchnic blood flow
  • Endoscopic: rubber band ligation (more effective) or sclerotherapy
  • Sengstaken-Blakemore tube: if persistently bleeding

Surgical Options

  • TIPS (transjugular intrahepatic portosystemic shunt): risk for hepatic encephalopathy
  • Distal splenorenal shunt: for esophageal variceal bleed; best with well-preserved liver
  • Rex shunt: for portal vein thrombosis; restores physiologic flow; improves growth and cognition
  • Liver transplant: for intrahepatic disease / cirrhosis / hepatopulmonary syndrome
  • β-blockers (non-selective): long-term; reduce heart rate by ≥25%

Prognosis

  • Intrahepatic: poor prognosis
  • Portal vein obstruction: >50% experience bleeding during adolescence; can develop portal biliopathy (bile duct compression from collaterals)

🟣 FULMINANT HEPATIC FAILURE (Acute Liver Failure)

Definition (Pediatric ALF)

  • Acute liver injury <8 weeks duration
  • No chronic liver disease
  • Coagulopathy:
    • PT >15 sec or INR >1.5 not corrected by Vit K + encephalopathy, OR
    • PT >20 sec or INR >2 (regardless of encephalopathy)

Causes

  • Viral: HAV, HBV, HCV, HEV + EBV, HSV, CMV, Adenovirus
  • Drugs: Acetaminophen = most common
  • Autoimmune hepatitis
  • Metabolic: Wilson disease, Galactosemia, Hereditary tyrosinemia
  • Vascular/ischemic

Warning Signs

  • Rapid decrease in liver size without clinical improvement = OMINOUS sign
  • Progressive jaundice, fetor hepaticus, fever, ascites, diathesis

Multi-Organ Involvement (Memorize!)

  • Brain: hepatic encephalopathy, cerebral edema, intracranial hypertension, seizures
  • Kidney: hepatorenal syndrome
  • Lungs: ARDS, hepatopulmonary syndrome
  • Heart: high output state
  • Bone marrow: anemia, thrombocytopenia
  • Liver: hypoglycemia, hyperammonemia, coagulopathy, lactic acidosis

Labs

  • Bilirubin + aminotransferases: markedly elevated
  • Aminotransferase decreases as patient deteriorates (bad sign!)
  • PT/INR prolonged (often don't normalize)
  • Hypoglycemia, hypokalemia, hyponatremia, metabolic acidosis

Treatment - Specific Antidotes (HIGH-YIELD!)

CauseTreatment
AcetaminophenN-acetylcysteine
Herpes simplexAcyclovir
Amanita mushroomsPenicillin
HBVEntecavir or Lamivudine
Autoimmune hepatitisPrednisone
Others (valproic acid)IV L-carnitine
  • Liver transplant: hepatic encephalopathy stages III-IV

Prognosis

  • 90% survival: Acetaminophen OD + Fulminant Hepatitis A
  • 40% survival: Idiopathic + acute-onset Wilson disease
  • Extremely poor: stage IV coma
  • Associated with mortality: Age <1 yr, Stage 4 encephalopathy, INR >4

🟡 ASCITES

  • Hallmark: abdominal distention
  • Signs: bulging flanks, shifting dullness, fluid wave, puddle sign
  • Moderate: early satiety, dyspnea
  • Tense: umbilical herniation

SERUM-ASCITES ALBUMIN GRADIENT (SAAG)

SAAGCause
>1.1 g/dL (high gradient)Portal hypertension
<1.1 g/dL (low gradient)Non-portal hypertensive (infection, malignancy)

Treatment

  • Sodium restriction + Spironolactone + Furosemide
  • Albumin infusion
  • Large volume paracentesis or TIPS
  • Risk: Spontaneous bacterial peritonitis (SBP)

🔴 PERITONITIS

Primary (Spontaneous Bacterial) Peritonitis

  • No intraabdominal source
  • Most common in: Cirrhosis and Nephrotic syndrome
  • Pathogen: Pneumococci most common; also Gr A strep, E. coli, Klebsiella
  • Paracentesis: WBC ≥250 cells/mm³ with >50% PMN
  • Treatment: Cefotaxime (broad spectrum initially); vancomycin for resistant pneumococci; 10-14 days
  • Monomicrobial

Secondary Peritonitis

  • Has an intraabdominal source
  • Most common: Perforated appendix
  • In neonates: Necrotizing enterocolitis
  • Paracentesis: WBC ≥250 + elevated protein (>1 g/dL) + low glucose (<50 mg/dL)
  • X-ray: Free air in peritoneal cavity
  • Treatment: Polymicrobial coverage
    • Lower GIT perforation: Ampicillin + Gentamicin + Clindamycin/Metronidazole
    • PD catheter-related: Intraperitoneal Cefepime or Cefazolin + Ceftazidime
  • Surgery once stabilized

⚡ RAPID MCQ FIRE - KEY NUMBERS

FactNumber
Jaundice = bilirubin>1 mg/dL
HAV incubation (shortest!)15-19 days
HBV incubation~3 months
Perinatal HBV transmission (untreated HBeAg+)up to 90%
Portal HTN pressure>10-12 mm Hg (normal 7)
Severe pancreatitis mortality20%
Lipase peak24-48 hr, stays up 8-14 days
ALF duration<8 weeks
ALF INR (with encephalopathy)>1.5
ALF INR (without encephalopathy)>2
SAAG for portal HTN>1.1 g/dL
SBP paracentesis WBC≥250 cells/mm³, >50% PMN
AIH remission rate>75%
AIH relapse rate50%
Wilson's liver transplant survival85-90%
ALF survival in acetaminophen/HAV90%
Choledochal cyst: cases in childhood75%
Liver abscess: right lobe75%, solitary 70%
Pigment stones in children70%
Cholelithiasis with symptoms>50%
Cholelithiasis with complications18%
HAV communicability before jaundice2 weeks
β-blocker: heart rate reduction goal≥25%

🔑 TOP MCQ TRIGGERS - WHAT DIAGNOSES WHAT?

ScenarioAnswer
Child <5, fasting, stress → jaundiceGilbert syndrome
Phenobarbital treats hyperbilirubinemiaCrigler-Najjar Type 2
Fecal-oral hepatitis, shortest incubationHAV
dsDNA virus, immune-mediated hepatitisHBV
Fatty change in hepatitisHCV
Female, anti-LKM1, severe, childhoodAIH Type 2
Female, ANA + anti-SMAAIH Type 1
ATP7B mutation, copper, Kayser-FleischerWilson disease
D-Penicillamine, Zinc treatmentWilson disease
Periumbilical + flank bruising in pancreatitisCullen + Grey Turner = Severe
Best test for pancreatitisLipase
Gallstone imaging of choiceUltrasonography
Ceftriaxone → biliary sludgeBiliary pseudolithiasis
N-acetylcysteine antidoteAcetaminophen toxicity
IV L-carnitine antidoteValproic acid toxicity
Hepatofugal flow on DopplerPortal HTN + variceal bleeding
Child <6, isolated splenomegaly, neonatal hxPortal vein obstruction
Best noninvasive predictors portal HTNPlatelet count + spleen length + albumin
Rex shunt used forPortal vein thrombosis
SAAG >1.1Portal hypertension
Ascites + no intraabdominal sourcePrimary/SBP
SBP most common organismPneumococcus
SBP antibioticCefotaxime
Perforated appendix peritonitisSecondary peritonitis
Classic triad older child biliaryPain + Jaundice + Mass = Choledochal cyst
Acalculous cholecystitis organismStreptococcus (Grp A & B)
Liver abscess: most common lobeRight lobe (75%)

Good luck on your exam! You've got this. 💪
This is a shared conversation. Sign in to Orris to start your own chat.